fda glp-1 warning 2025 november From a new Perspective by Amanda Banks, MD: On February 5, 2026, Hims & Hers, an online health and wellness platform, announced its intention to sell compounded oral semaglutide, a glucagon-like peptide-1 ( GLP-1 Pipeline Update: August 2025

While telehealth can increase patient access to medications, it is critical to ensure that prescribing practices adhere to accepted standards outlined in clinical practice guidelines

Keto Certified, plant-based sugar, naturally sweet, and perfectly portioned

#Lilly #HanmiPharmaceutical #GLP2 #Sonefpeglutide #ShortBowelSyndrome #Gastroenterology #RareDisease #Biotech #DrugDevelopment #Pharma #HealthcareInnovation #Biologics #LicensingDeal #PrecisionMedicine

Note for Washington State Providers: For commercial plans, your effective date for changes described in this article will be communicated to you following regulatory review

Curious about how GLP-1 weight loss injections work for residents in Bethesda, MD